Follow-on Roundup: Arrowhead, Kodiak, Relmada, Revance

Since market close on Tuesday, Arrowhead, Kodiak, Relmada and Revance raised a total of $718.5 million in follow-ons.

Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) raised $232 million after it priced an offering of 4 million shares at $58 a share, an 8% discount from Monday’s close of $63.33. Underwriters were Goldman Sachs, Jefferies, Piper Jaffray, Cantor Fitzgerald, Robert W. Baird, and B. Riley FBR. ...